PetCure Oncology, which rolled out stereotactic radiosurgery for cancer-stricken pets just over a year ago, has big expansion plans. The Chicago company wants to open three more treatment sites in 2016 and operate 30 nationwide within five years. PetCure now has clinics in suburban Phoenix, Cincinnati, Clifton, N.J., and Milwaukee. Through May, about 300 patients, mostly dogs, had been treated by PetCure doctors. Stereotactic radiosurgery is noninvasive. Radiation is delivered precisely to diseased tissue, offering fewer side effects and treatment sessions compared to conventional radiation therapy, the company stated. A nine-member scientific advisory board is made up of experts in the fields of veterinary and human oncology, stereotactic radiosurgery and medical physics. “The board has worked hard to establish data-driven delivery protocols and implement human-caliber quality-control standards,” CEO Scott Milligan said. Originally published in the August 2016 issue of Veterinary Practice News. Did you enjoy this article? Then subscribe today!
